Can I Have APS If Standard Tests Are Negative? Explained
At a Glance
Negative standard APS tests mean you do not meet formal classification criteria, but they do not explain a documented clot or pregnancy loss. Specialists review test timing and blood thinner interference, confirm the event, and investigate other causes before considering seronegative APS.
It can be deeply frustrating to experience life-altering blood clots or pregnancy losses, only to be told your antiphospholipid antibody tests are completely negative. In the medical community, having APS-like events with negative standard tests is sometimes referred to as seronegative APS. However, “seronegative APS” remains a controversial label and is not recognized as an official diagnosis by international classification criteria [1][2].
Because there are no universally accepted diagnostic criteria for seronegative APS, doctors generally consider it a diagnosis of exclusion [3]. A negative standard panel means you do not meet formal classification criteria for APS, but it does not mean your symptoms are dismissed. Rather, your medical team must first rule out false-negative test results and thoroughly investigate other causes before considering this label.
What Counts as an APS Event?
APS is not diagnosed based on vague symptoms. Formal classification requires an objectively confirmed clinical event: either a documented blood clot (thrombosis in a vein, artery, or small vessel) or specific, strictly defined pregnancy morbidities (such as recurrent early miscarriages or late-pregnancy losses) [4][5].
Were the Tests Done Correctly?
Before concluding that you are truly “seronegative,” a specialist will review whether your standard testing was thorough and accurate. The standard APS panel requires persistent positivity on at least one of three specific tests: the lupus anticoagulant (LA), anticardiolipin antibodies (aCL), and anti-β2-glycoprotein I antibodies (anti-β2GPI), confirmed again at least 12 weeks later [2][6].
Testing can sometimes yield misleading results due to several factors:
- Anticoagulant Interference: The lupus anticoagulant (LA) test is a functional clotting assay. This means blood thinners (anticoagulants) like warfarin, heparin, or direct oral anticoagulants (DOACs) can severely interfere with the results, causing false negatives or uninterpretable false positives [7]. Safety Warning: Never stop, skip, or alter your prescribed blood thinners just to get a blood test. Your doctor and laboratory must coordinate the safest way to test you, which may involve specialized mitigation methods.
- Incomplete Testing: Lupus anticoagulant testing normally requires multiple complex laboratory steps. Furthermore, because different laboratories use different testing methods, a negative result on one type of test might miss a positive result on another [8][9].
- Timing and Transient Positives: Acute infections or severe inflammation can cause temporarily positive antibody results that disappear later, which is why a positive test must always be repeated after 12 weeks [10]. Conversely, while some antibody levels can change during early pregnancy, this does not automatically invalidate all testing [11].
Table: The Three Standard APS Tests
| Test Name | What It Is | Can Blood Thinners Interfere? |
|---|---|---|
| Lupus Anticoagulant (LA) | Functional clotting assay | Yes (Strong interference from DOACs, warfarin, heparin) [7] |
| Anticardiolipin (aCL) | Solid-phase immunoassay (IgG/IgM) | No (generally unaffected) [8] |
| Anti-β2-Glycoprotein I | Solid-phase immunoassay (IgG/IgM) | No (generally unaffected) [8] |
What a Negative Panel Does and Does Not Mean
- It does not confirm seronegative APS. A negative panel is a reason to look for other answers, not an automatic confirmation of a hidden APS diagnosis [3].
- It does not rule out all APS risk if testing was flawed. If you were tested while on blood thinners or during an acute illness, the results might need specialist review [7].
- It does not dictate your treatment. Your treatment—such as whether you need blood thinners—is driven by your documented history of clots or pregnancy losses, not just a blood test [12].
Non-Criteria Antibodies
If your standard tests are definitively negative, researchers have identified several non-criteria antibodies—such as anti-phosphatidylserine/prothrombin (aPS/PT) and anti-domain I β2-glycoprotein I [13][14].
While these tests are sometimes positive in patients who test negative on the standard panel, they are not part of current classification criteria and are not uniformly standardized across laboratories [15]. Importantly, a positive result on a non-criteria test does not by itself prove you have APS, nor does it automatically determine your need for anticoagulation or specific pregnancy treatments [16][9]. Specialists typically only order these when the result will meaningfully change your medical management.
Evaluating Other Causes
A major reason to verify your antibody status is to ensure other dangerous or treatable conditions are not missed [3].
- Other autoimmune diseases: Systemic lupus erythematosus (SLE) can independently increase your risk of clotting and pregnancy complications [3][12].
- Inherited thrombophilia: Conditions like Factor V Leiden increase clotting risk. However, testing is selective and not routinely indicated for every pregnancy loss [5]. While autoimmune susceptibility can cluster in families, APS itself is generally an acquired autoimmune condition, not a simple inherited genetic trait [3].
- Obstetric and structural causes: Recurrent pregnancy loss requires its own specific evaluation for chromosomal abnormalities, endocrine disorders (like thyroid issues), and physical variations in the uterus [5].
If you have a history of clots or pregnancy loss, a hematologist or maternal-fetal medicine specialist can help determine the safest path forward. Always seek emergency medical care if you develop sudden symptoms like chest pain, severe breathlessness, one-sided leg swelling, or stroke-like symptoms, regardless of your antibody status.
Common questions in this guide
Can I still have APS if all three standard antibody tests are negative?
What tests make up the standard APS antibody panel?
Can blood thinners make an APS test look negative?
Are non-criteria antibody tests useful when standard APS tests are negative?
What other conditions should be checked after clots or pregnancy loss with negative APS tests?
Which specialist can evaluate possible seronegative APS?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Were all three standard tests (LA, aCL, anti-β2GPI) performed, and were they the correct IgG/IgM types?
- 2.How might the blood thinners I am taking have affected my lupus anticoagulant test, and should we coordinate with the lab to retest safely?
- 3.Would checking for non-criteria antibodies like aPS/PT actually change my treatment plan, or is my current clinical history enough to guide management?
- 4.Should we investigate other causes for my events, such as inherited thrombophilias, chromosomal issues, or structural variations?
- 5.Who should be on my care team moving forward—do I need a maternal-fetal medicine specialist or a hematologist to oversee my case?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (16)
- 1
"Non-criteria" antiphospholipid syndrome: A nomenclature proposal.
Pires da Rosa G, Bettencourt P, Rodríguez-Pintó I, et al.
Autoimmunity reviews 2020; (19(12)):102689 doi:10.1016/j.autrev.2020.102689.
PMID: 33223008 - 2
[Seronegative antiphospholipid syndrome: Myth or reality?]
Salle V
La Revue de medecine interne 2020; (41(4)):265-274 doi:10.1016/j.revmed.2020.02.005.
PMID: 32115196 - 3
Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical management.
Pignatelli P, Ettorre E, Menichelli D, et al.
Haematologica 2020; (105(3)):562-572 doi:10.3324/haematol.2019.221945.
PMID: 32001534 - 4
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
Barbhaiya M, Zuily S, Naden R, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2023; (75(10)):1687-1702 doi:10.1002/art.42624.
PMID: 37635643 - 5
Dilemmas in the diagnosis and management of antiphospholipid syndrome.
Manning JE, Arachchillage DJ
Journal of thrombosis and haemostasis : JTH 2024; (22(8)):2156-2170 doi:10.1016/j.jtha.2024.03.027.
PMID: 38705387 - 6
Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances.
Vandevelde A, Devreese KMJ
Journal of clinical medicine 2022; (11(8)) doi:10.3390/jcm11082164.
PMID: 35456258 - 7
Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis.
Tripodi A, Cohen H, Devreese KMJ
Journal of thrombosis and haemostasis : JTH 2020; (18(7)):1569-1575 doi:10.1111/jth.14846.
PMID: 32619349 - 8
Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity.
Simmons DP, Herskovits AZ, Battinelli EM, et al.
Clinical chemistry and laboratory medicine 2018; (56(8)):1289-1296.
PMID: 27305702 - 9
Solid Phase Assays for Antiphospholipid Antibodies.
Devreese KMJ
Seminars in thrombosis and hemostasis 2022; (48(6)):661-671 doi:10.1055/s-0042-1744364.
PMID: 35675831 - 10
Laboratory Diagnostics in Thrombophilia.
Linnemann B, Hart C
Hamostaseologie 2019; (39(1)):49-61 doi:10.1055/s-0039-1677840.
PMID: 30703819 - 11
Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.
Yelnik CM, Porter TF, Branch DW, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2016; (68(8)):1964-9 doi:10.1002/art.39668.
PMID: 26990620 - 12
The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study.
da Rosa GP, Sousa-Pinto B, Ferreira E, et al.
Arthritis research & therapy 2022; (24(1)):9 doi:10.1186/s13075-021-02702-9.
PMID: 34980238 - 13
"Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort.
Liu T, Gu J, Wan L, et al.
Arthritis research & therapy 2020; (22(1)):33 doi:10.1186/s13075-020-2131-4.
PMID: 32085759 - 14
Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome.
Zhang S, Wu Z, Zhang W, et al.
Clinical chemistry and laboratory medicine 2018; (56(6)):939-946 doi:10.1515/cclm-2017-0811.
PMID: 29561729 - 15
Current Promising Biomarkers and Methods in the Diagnostics of Antiphospholipid Syndrome: A Review.
Bradacova P, Slavik L, Ulehlova J, et al.
Biomedicines 2021; (9(2)) doi:10.3390/biomedicines9020166.
PMID: 33567576 - 16
Testing for antiphospholipid antibodies: Advances and best practices.
Devreese KMJ
International journal of laboratory hematology 2020; (42 Suppl 1()):49-58 doi:10.1111/ijlh.13195.
PMID: 32543059
This page is for informational purposes only and does not constitute medical advice about possible seronegative APS. Do not stop or change blood thinners without guidance from your prescribing clinician; discuss testing with a hematologist or maternal-fetal medicine specialist.
Get notified when new evidence is published on familial antiphospholipid syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.